Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Terminated
Low Recruitment
Other terminated trials from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Oligometastatic Disease · Apr 2026
- Systemic Sclerosis · Phase PHASE1 · Nov 2024
- Renal Cell Carcinoma Metastatic · Phase NA · Apr 2024
- Pancreas Cancer · Phase NA · Aug 2023
- Glioma, Malignant · Aug 2022
See all terminations from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Other Gastrointestinal Cancer trials with similar outcome
Listed as NCT00539318, this observational or N/A phase trial focuses on Gastrointestinal Cancer and remains terminated or withdrawn. Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Aug 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Singapore Cancer Syndicate.
For direct contact, visit the study record on ClinicalTrials.gov .